IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
iBio, Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 28, 2026
$0.76−0.01 (-0.81%)
Close on Oct 19, 2026
- Market cap
- $110.48M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Nov 29, 2023 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Nov 29, 2023 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Oct 10, 2022 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Oct 7, 2022 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Sep 18, 2018(first seen in filings) | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Jun 11, 2018 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |